These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14770293)

  • 1. Novel estrogen receptor coregulators and signaling molecules in human diseases.
    Barnes CJ; Vadlamudi RK; Kumar R
    Cell Mol Life Sci; 2004 Feb; 61(3):281-91. PubMed ID: 14770293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological role of estrogen and estrogen receptors.
    Nilsson S; Gustafsson JA
    Crit Rev Biochem Mol Biol; 2002; 37(1):1-28. PubMed ID: 11905545
    [No Abstract]   [Full Text] [Related]  

  • 3. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation.
    DiRenzo J; Shang Y; Phelan M; Sif S; Myers M; Kingston R; Brown M
    Mol Cell Biol; 2000 Oct; 20(20):7541-9. PubMed ID: 11003650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection and estrogen receptors.
    Simpkins JW; Singh M; Brock C; Etgen AM
    Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
    Correia SC; Santos RX; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Curr Aging Sci; 2010 Jul; 3(2):113-26. PubMed ID: 20167003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.
    Prossnitz ER; Arterburn JB
    Pharmacol Rev; 2015 Jul; 67(3):505-40. PubMed ID: 26023144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
    Prossnitz ER; Arterburn JB; Smith HO; Oprea TI; Sklar LA; Hathaway HJ
    Annu Rev Physiol; 2008; 70():165-90. PubMed ID: 18271749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta.
    Cheung E; Schwabish MA; Kraus WL
    EMBO J; 2003 Feb; 22(3):600-11. PubMed ID: 12554660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen as a neuroprotective hormone.
    Behl C
    Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: Recent advances in extranuclear steroid receptor actions.
    Hammes SR; Levin ER
    Endocrinology; 2011 Dec; 152(12):4489-95. PubMed ID: 22028449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.
    Lindsey SH; Chappell MC
    Gend Med; 2011 Dec; 8(6):343-54. PubMed ID: 22153880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-genomic regulation of vascular cell function and growth by estrogen.
    Meyer MR; Haas E; Prossnitz ER; Barton M
    Mol Cell Endocrinol; 2009 Sep; 308(1-2):9-16. PubMed ID: 19549587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconventional Estrogen Signaling in Health and Disease.
    Faltas CL; LeBron KA; Holz MK
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32128594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methylation in estrogen signaling and estrogen-related cancers.
    Teyssier C; Le Romancer M; Sentis S; Jalaguier S; Corbo L; Cavaillès V
    Trends Endocrinol Metab; 2010 Mar; 21(3):181-9. PubMed ID: 20005732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
    Talukder AH; Gururaj A; Mishra SK; Vadlamudi RK; Kumar R
    Mol Cell Biol; 2004 Aug; 24(15):6581-91. PubMed ID: 15254226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-estrogen receptor signaling suppresses the transcription of ERRF in breast cancer cells.
    Luo A; Su D; Zhang X; Qi L; Fu L; Dong JT
    J Genet Genomics; 2016 Sep; 43(9):565-567. PubMed ID: 27599921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.